Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Short-term Investments (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Short-term Investments for 15 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Short-term Investments rose 1.43% to $3.0 million in Q4 2025 year-over-year; TTM through Nov 2025 was $3.0 million, a 1.43% increase, with the full-year FY2025 number at $3.0 million, up 1.43% from a year prior.
  • Short-term Investments was $3.0 million for Q4 2025 at Cryo Cell International, down from $4.3 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $4.3 million in Q2 2025 to a low of $17620.0 in Q4 2022.
  • A 5-year average of $1.1 million and a median of $574183.0 in 2023 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: plummeted 91.89% in 2021, then surged 3158.7% in 2023.
  • Cryo Cell International's Short-term Investments stood at $75412.0 in 2021, then tumbled by 76.64% to $17620.0 in 2022, then soared by 3158.7% to $574183.0 in 2023, then surged by 411.19% to $2.9 million in 2024, then rose by 1.43% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Short-term Investments are $3.0 million (Q4 2025), $4.3 million (Q2 2025), and $3.3 million (Q1 2025).